| 2024/04/12 12:46:57 | |
|---|---|
| Price | |
| 242.60 CHF | |
| Difference | -0.57% (-1.40) |
General attributes
| ISIN | CH0012032113 |
| Symbol | RO |
| Exchange | London Stock Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 182,271 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 256.00 CHF (5) |
| Ask (Ask size) | - CHF (0) |
| Open | 242.60 CHF |
| High | 242.60 CHF |
| Low | 242.60 CHF |
| Close (prev. day) | 244.00 CHF |
| VWAP | 242.60 CHF |
| Volume (pcs) | 26 |
| Trading volume | 6,307.60 |
| Number of trades | 1 |
| Last size | 26 |
Futures and Options
| Related Futures | - |
| Related Options | 541 |
PDF Downloads
| Company report: ROCHE HOLDING AG |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/12 12:46:57 | |
|---|---|
| Price | |
| 242.60 CHF | |
| Difference | -0.57% (-1.40) |
General attributes
| ISIN | CH0012032113 |
| Symbol | RO |
| Exchange | London Stock Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 182,271 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 256.00 CHF (5) |
| Ask (Ask size) | - CHF (0) |
| Open | 242.60 CHF |
| High | 242.60 CHF |
| Low | 242.60 CHF |
| Close (prev. day) | 244.00 CHF |
| VWAP | 242.60 CHF |
| Volume (pcs) | 26 |
| Trading volume | 6,307.60 |
| Number of trades | 1 |
| Last size | 26 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | - | - | - |
| Perf (abs.) | - | - | - |
| Beta | 1.24 | 1.09 | 0.86 |
| Volatility | 2.46 | 7.60 | 5.52 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 242.60 CHF (161) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 242.36 CHF (146) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 249.77 CHF (245) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 267.05 CHF (348) |
| YTD High | date | 273.80 CHF (2024/01/10) |
| YTD Low | date | 229.80 CHF (2024/04/08) |
| 52 Weeks High | date | 314.80 CHF (2023/05/15) |
| 52 Weeks Low | date | 229.80 CHF (2024/04/08) |
All listings for ROCHE HOLDING AG
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| SIX Swiss Exchange | 2024/04/18 | 17:30 | 236.80 CHF | 6.58 | 803 |
| London Stock Exchange | 2024/04/12 | 12:46 | 242.60 CHF | 0.01 | 1 |
| Hanover | 2019/06/28 | 08:01 | 245.60 EUR | 0.00 | 2 |
| Hamburg | 2019/06/28 | 15:40 | 245.20 EUR | 0.00 | 2 |
| Frankfurt | 2019/06/28 | 17:41 | 247.60 EUR | 0.11 | 7 |
| FINRA other OTC Issues | 2024/04/18 | 19:29 | 263.00 USD | 0.01 | 2 |
| Duesseldorf | 2019/06/28 | 08:11 | 245.40 EUR | 0.00 | 2 |
| Berlin | 2019/06/28 | 18:47 | 247.00 EUR | 0.00 | 13 |
Company Logo
Contact Details
| ROCHE HOLDING AG |
| - - |
| Grenzacherstrasse 124 - 4058 Basel |
| Telefon: +41-61-688-11-11 |
| Fax: +41-61-691-93-91 |
| E-mail: - |
PDF Downloads
| Company report: ROCHE HOLDING AG | |
Company Profile
Roche Holding AG is a research healthcare company. It operates through the Pharmaceuticals and Diagnostics segments. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. |
Members of Management Board
| Thomas Schinecker | Chairman of Managing Board |
| Alan Hippe | Member of Executive Committee |
| Aviv Regev | Member of Executive Committee |
| Dr. Hans Clevers | Member of Executive Committee |
| James H. Sabry | Member of Executive Committee |
| Levi Garraway | Member of Executive Committee |
| Barbara Schädler | Member of Executive Committee |
| Claudia Böckstiegel | Member of Executive Committee |
| Cristina A. Wilbur | Member of Executive Committee |
| Matt Sause | Member of Executive Committee |
| Silke Hörnstein | Member of Executive Committee |
| Teresa Graham | Member of Executive Committee |
Board of directors
| Akiko Iwasaki | Member of the administrative board |
| Claudia Dyckerhoff | Member of the administrative board |
| Jemilah Mahmood | Member of the administrative board |
| Joerg Duschmale | Member of the administrative board |
| Patrick Frost | Member of the administrative board |
| Richard Lifton | Member of the administrative board |
| Ulf Mark Schneider | Member of the administrative board |
| André Hoffmann | Member of the administrative board |
| Anita Hauser | Member of the administrative board |
| Bernard Poussot | Member of the administrative board |
| Severin Schwan | Chairman of the administrative boar |